Solasia Pharma KK Price Chart
Solasia Pharma KK 9SO.SG Financial and Trading Overview
| Solasia Pharma KK stock price | 0.15 EUR |
| Previous Close | 0.26 EUR |
| Open | 0.27 EUR |
| Bid | 0.27 EUR x 0 |
| Ask | 0.29 EUR x 0 |
| Day's Range | 0.27 - 0.27 EUR |
| 52 Week Range | 0.26 - 0.5 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 17.57M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.166 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9SO.SG Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.8913648 |
| Price/Book (mrq) | 0.5678497 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Solasia Pharma KK Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.5 EUR |
| 52 Week Low | 0.26 EUR |
| 50-Day Moving Average | 0.29 EUR |
| 200-Day Moving Average | 0.32 EUR |
9SO.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 64.61M |
| Float | 31.47M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2016 |
| Most Recent Quarter (mrq) | December 31, 2016 |
| Next Fiscal Year End | December 31, 2018 |
Profitability
| Profit Margin | -94.61% |
| Operating Margin (ttm) | -92.21% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -7.38% |
| Return on Equity (ttm) | -21.39% |
Income Statement
| Revenue (ttm) | 4.52M EUR |
| Revenue Per Share (ttm) | 0.11 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 410M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -6866045 EUR |
| Diluted EPS (ttm) | -0.166 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.36M EUR |
| Total Cash Per Share (mrq) | 0.11 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.947 |
| Book Value Per Share (mrq) | 0.479 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4182496 EUR |
| Levered Free Cash Flow (ttm) | -7560492 EUR |
Profile of Solasia Pharma KK
| Country | Germany |
| State | N/A |
| City | Tokyo |
| Address | Shiodome Building |
| ZIP | 105-0022 |
| Phone | 81 3 6721 8332 |
| Website | https://www.solasia.co.jp |
| Industry | |
| Sector(s) | |
| Full Time Employees | 16 |
Solasia Pharma K.K., a specialty pharmaceutical company, develops, imports/exports, and markets pharmaceutical products and medical devices, etc. in Japan. It offers SP-01 Sancuso, a transdermal delivery system that delivers the anti-emetic and granisetron into the patients bloodstream to patients receiving chemotherapy; and SP-02 Darinaparsin, a mitochondrial-targeted agent for the treatment of various hematologic and solid cancers, as well as SP-03 episil, an oral liquid for the treatment of pain associated with oral mucositis. The company was founded in 2006 and is based in Tokyo, Japan.
Q&A For Solasia Pharma KK Stock
What is a current 9SO.SG stock price?
Solasia Pharma KK 9SO.SG stock price today per share is 0.15 EUR.
How to purchase Solasia Pharma KK stock?
You can buy 9SO.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Solasia Pharma KK?
The stock symbol or ticker of Solasia Pharma KK is 9SO.SG.
How many shares does Solasia Pharma KK have in circulation?
The max supply of Solasia Pharma KK shares is 64.61M.
What is Solasia Pharma KK Price to Earnings Ratio (PE Ratio)?
Solasia Pharma KK PE Ratio is now.
What was Solasia Pharma KK earnings per share over the trailing 12 months (TTM)?
Solasia Pharma KK EPS is -0.166 EUR over the trailing 12 months.